The parents of a 21-year-old woman with a heart condition who died after consuming a heavily caffeinated energy drink at a Panera Bread location have filed a wrongful death suit against the renowned restaurant chain. They alleged that their daughter may have mistaken the beverage for regular lemonade.
The lawsuit, filed in Philadelphia, seeks compensatory and punitive damages, reports CNN.
Medical Examiner's Determination and Pre-Existing Condition
In September 2022, Sarah Katz suffered cardiac arrest after consuming Panera's "Charged Lemonade" while dining with friends. Despite prompt transportation to the hospital, she experienced a second arrest and ultimately succumbed to her condition.
According to the autopsy report obtained from a reliable source, the cause of death was attributed to cardiac arrhythmia resulting from long QT syndrome (LQTS). Sarah had been diagnosed with LQTS at a young age and managed her symptoms through medication and caffeine restriction, the lawsuit specifies, according to NBC.
Misleading Marketing and Inadequate Labeling
Many energy drinks contain substantial amounts of caffeine, added sugars, B vitamins, and other legal stimulants. Panera's "Charged Lemonade" is no exception, with ingredients like sugar, caffeine, coffee extract, and guarana extract, all of which contribute to its caffeine content.
The lawsuit contends that Panera failed to appropriately label the "Charged Lemonade" as an energy drink, causing significant consumer confusion. Panera's marketing materials touted the product as "Plant-based and Clean with as much caffeine as our Dark Roast Coffee." However, details regarding the equivalence between the Dark Roast coffee and the Charged Lemonade were omitted, leading to ambiguity and misinformation.
Online, Panera claims that its "Charged Lemonade" contains a comparable level of caffeine to its Dark Roast coffee. A large-sized Charged Lemonade served in a 30-ounce cup packs approximately 390 mg of caffeine.
The U.S. Food and Drug Administration recommends a daily caffeine intake of up to 400 milligrams for healthy adults, equating to around four or five cups of coffee.
Uncontrolled Caffeine Content in In-House Mixing
Panera's "Charged Lemonade" is prepared in-house by store employees, implying a lack of control over its caffeine content. This unregulated preparation method presents inherent dangers and the potential for considerable variation, making it difficult for consumers to assess their caffeine intake accurately.
Legal Action for Greater Responsibility
The lawsuit against Panera aims to seek justice for Sarah Katz and prompt responsible marketing practices across the industry.
"We want to make sure that the drink includes a warning, or is taken off the shelf," Elizabeth Crawford, the attorney representing Katz's parents, said. "It's a dangerous energy drink and it's not advertised that way. We want to make sure this does not happen to someone else."


Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
FDA Fast-Track Drug Reviews Delayed Over Safety and Efficacy Concerns
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 



